Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroendocrine Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT02457650
What this trial is testing

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Who this might be right for
Bladder CarcinomaBreast CancerEsophagus Carcinoma+7 more
Shenzhen Second People's Hospital 36
Early research (Phase 1)Ended earlyNCT05573035
What this trial is testing

Investigate LYL845 in Adults With Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerColorectal Cancer
Lyell Immunopharma, Inc. 39
Testing effectiveness (Phase 2)WithdrawnNCT06090318
What this trial is testing

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Who this might be right for
Advanced Solid TumorCDKN2ANSCLC+7 more
Rain Oncology Inc
Not applicableStudy completedNCT01425710
What this trial is testing

Non-invasive Evaluation of Fluid Status and Cardiac Output During Operative Treatment of Pheochromcytoma

Who this might be right for
Pheochromocytoma
Medical University of Vienna 15
Testing effectiveness (Phase 2)Study completedNCT02285413
What this trial is testing

Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients

Who this might be right for
Melanoma
Radboud University Medical Center 54
Testing effectiveness (Phase 2)Study completedNCT02305810
What this trial is testing

A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus

Who this might be right for
Pancreatic Neuroendocrine Tumour Metastatic
European Institute of Oncology 54
Large-scale testing (Phase 3)Looking for participantsNCT07015190
What this trial is testing

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Who this might be right for
Uveal Melanoma
IDEAYA Biosciences 520
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05893654
What this trial is testing

Melphalan Chemoreduction for Ocular Melanoma

Who this might be right for
Uveal Melanoma
Hospital das Clínicas de Ribeirão Preto 10
Early research (Phase 1)Ended earlyNCT07121829
What this trial is testing

Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorPilocytic Astrocytoma+7 more
Day One Biopharmaceuticals, Inc. 44
Very early researchStudy completedNCT00743353
What this trial is testing

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

Who this might be right for
SarcomaMelanomaLung Cancer+2 more
Siemens Molecular Imaging 16
Not applicableUnknownNCT03797053
What this trial is testing

Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology

Who this might be right for
MelanomaCirculating Tumor Cell
Assistance Publique - Hôpitaux de Paris 450
Early research (Phase 1)Ended earlyNCT05061537
What this trial is testing

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Renal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more
Pfizer 13
Early research (Phase 1)Study completedNCT01625351
What this trial is testing

CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Who this might be right for
Ewing SarcomaGastrointestinal TumorGerm Cell Tumor+10 more
St. Jude Children's Research Hospital 23
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Testing effectiveness (Phase 2)Study completedNCT00089063
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+6 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00405587
What this trial is testing

Safety Study of PLX4032 in Patients With Solid Tumors

Who this might be right for
Malignant MelanomaColorectal Carcinoma
Plexxikon 109
Not applicableNot Yet RecruitingNCT07653087
What this trial is testing

Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk Melanoma

Who this might be right for
Sentinel Lymph Node Biopsy (SLNB)Melanoma (Skin Cancer)
University of Virginia 66
Not applicableActive Not RecruitingNCT04467021
What this trial is testing

Cancer and Blood Pressure Management, CARISMA Study

Who this might be right for
Cardiovascular DisorderChronic Kidney DiseaseMetastatic Renal Cell Carcinoma+6 more
ECOG-ACRIN Cancer Research Group 61
Not applicableEnded earlyNCT03986593
What this trial is testing

Cryoablation of Bone Metastases From Endocrine Tumors

Who this might be right for
Neoplasm MetastasisThyroid NeoplasmPheochromocytoma+3 more
Instituto do Cancer do Estado de São Paulo 17
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06848088
What this trial is testing

Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 48
Next Page